Clinical trial
A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes
NCT02846545
Study timeline
Study start (actual)2016-08-26Date precision: day
Registry last updated2025-02-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
Sponsors & collaborators
Janssen Research & Development, LLClead sponsor
Mapped research locations
BostonMassachusetts, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1San DiegoCalifornia, United States1IndianapolisIndiana, United States1AuroraColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02846545 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.